SELENIOUS ACID
| Brand name | SELENIOUS ACID |
|---|---|
| Active ingredient | SELENIOUS ACID |
| Strength | EQ 60MCG SELENIUM/ML (EQ 60MCG SELENIUM/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | January 2021 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12150957 | July 2041 | use U-4039 |
| 11998565 | July 2041 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.